ACTUAL MEDICAL MELUN 1328 : revenue, balance sheet and financial ratios

ACTUAL MEDICAL MELUN 1328 is a French company founded 16 years ago, specialized in the sector Activités des agences de travail temporaire . Based in MELUN (77000), this company of category PME shows in 2024 a revenue of 3.5 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - ACTUAL MEDICAL MELUN 1328 (SIREN 519607345)
Indicator 2024 2023 2021 2020 2019 2018 2017 2016
Revenue 3 469 738 € N/C N/C N/C N/C N/C N/C 1 953 667 €
Net income 198 143 € 216 925 € 357 573 € 192 740 € 212 937 € 220 742 € 197 685 € 197 313 €
EBITDA 338 336 € N/C N/C N/C N/C N/C N/C 262 684 €
Net margin 5.7% N/C N/C N/C N/C N/C N/C 10.1%

Revenue and income statement

In 2024, ACTUAL MEDICAL MELUN 1328 achieves revenue of 3.5 M€. Over the period 2016-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +7.4%. After deducting consumption (2 k€), gross margin stands at 3.5 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 338 k€, representing 9.8% of revenue. This level of operating margin is satisfactory for the sector. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 198 k€, i.e. 5.7% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

3 469 738 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

3 467 648 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

338 336 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

259 480 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

198 143 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

9.8%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 38%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 47%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.8 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 8.0% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. Satisfactory level allowing partial financing of growth.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

37.871%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

47.168%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

7.973%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.85

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

8.4%

Solvency indicators evolution
ACTUAL MEDICAL MELUN 1328

Sector positioning

Debt ratio
37.87 2024
2021
2023
2024
Q1: 0.0
Med: 2.73
Q3: 26.78
Average +19 pts over 3 years

In 2024, the debt ratio of ACTUAL MEDICAL MELUN 1328 (37.87) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
47.17% 2024
2021
2023
2024
Q1: 11.73%
Med: 25.56%
Q3: 44.76%
Excellent

In 2024, the financial autonomy of ACTUAL MEDICAL MELUN 1328 (47.2%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
0.85 years 2024
2024
Q1: 0.0 years
Med: 0.0 years
Q3: 0.27 years
Average

In 2024, the repayment capacity of ACTUAL MEDICAL MELUN 1328 (0.85) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 283.83. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.4x. Danger: operating income does not cover interest charges, unsustainable situation.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

283.834

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

0.401

Liquidity indicators evolution
ACTUAL MEDICAL MELUN 1328

Sector positioning

Liquidity ratio
283.83 2024
2021
2023
2024
Q1: 111.16
Med: 138.5
Q3: 192.32
Excellent +8 pts over 3 years

In 2024, the liquidity ratio of ACTUAL MEDICAL MELUN 1328 (283.83) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
0.4x 2024
2024
Q1: -0.69x
Med: 0.0x
Q3: 1.34x
Good

In 2024, the interest coverage of ACTUAL MEDICAL MELUN 1328 (0.4x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 72 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 0 days. The gap of 72 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Overall, WCR represents 18 days of revenue, i.e. 175 k€ to permanently finance.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

175 395 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

72 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

18 j

WCR and payment terms evolution
ACTUAL MEDICAL MELUN 1328

Positioning of ACTUAL MEDICAL MELUN 1328 in its sector

Comparison with sector Activités des agences de travail temporaire

Valuation estimate

Based on 135 transactions of similar company sales (all years), the value of ACTUAL MEDICAL MELUN 1328 is estimated at 496 383 € (range 264 077€ - 1 142 134€). With an EBITDA of 338 336€, the sector multiple of 2.0x is applied. The price/revenue ratio is 0.08x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
135 transactions
264k€ 496k€ 1142k€
496 383 € Range: 264 077€ - 1 142 134€
NAF 5 all-time

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
338 336 € × 2.0x
Estimation 686 065 €
328 834€ - 1 616 207€
Revenue Multiple 30%
3 469 738 € × 0.08x
Estimation 266 936 €
209 491€ - 477 209€
Net Income Multiple 20%
198 143 € × 1.8x
Estimation 366 351 €
184 068€ - 954 341€
How is this estimate calculated?

This estimate is based on the analysis of 135 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Activités des agences de travail temporaire )

Compare ACTUAL MEDICAL MELUN 1328 with other companies in the same sector:

Voir toutes les statistiques du secteur Activités des agences de travail temporaire

Frequently asked questions about ACTUAL MEDICAL MELUN 1328

What is the revenue of ACTUAL MEDICAL MELUN 1328 ?

The revenue of ACTUAL MEDICAL MELUN 1328 in 2024 is 3.5 M€.

Is ACTUAL MEDICAL MELUN 1328 profitable?

Yes, ACTUAL MEDICAL MELUN 1328 generated a net profit of 198 k€ in 2024.

Where is the headquarters of ACTUAL MEDICAL MELUN 1328 ?

The headquarters of ACTUAL MEDICAL MELUN 1328 is located in MELUN (77000), in the department Seine-et-Marne.

Where to find the tax return of ACTUAL MEDICAL MELUN 1328 ?

The tax return of ACTUAL MEDICAL MELUN 1328 is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does ACTUAL MEDICAL MELUN 1328 operate?

ACTUAL MEDICAL MELUN 1328 operates in the sector Activités des agences de travail temporaire (NAF code 78.20Z). See the 'Sector positioning' section above to compare the company with its competitors.